secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001628280-23-006335
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus deconsolidates CartiHeal after settlement, records $88.5M loss on disposal
--------------------------------------------------------------------------------

- Transferred CartiHeal shares to trustee and paid $10M to former securityholders under settlement agreement.
- Deconsolidation effective Feb 27, 2023; CartiHeal treated as discontinued operation with $88.5M loss on disposal.
- Pro forma net loss for nine months ended Oct 1, 2022 increases to $134.3M from $126.8M historical.
- Settlement resolves non-payment of $50M milestone triggered Feb 13, 2023; company avoids litigation.
- Bioventus retains no ownership or voting rights in CartiHeal during interim period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000162828023006335/0001628280-23-006335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000162828023006335/bvs-20230227.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-006335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer